BCTX: BriaCell Therapeutics Corp. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
18 institutions reported holding $1.46M of BriaCell Therapeutics Corp. on Form 13F (16 the quarter before). 3 opened a new position and 1 sold out. Shares held by institutions: +17%.
| Largest holders | Shares | Value |
|---|---|---|
| Cable Car Capital, LP | 216,821 | $702K |
| SABBY MANAGEMENT, LLC | 80,721 | $262K |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 65,000 | $211K |
| UBS Group AG | 43,642 | $141K |
| JANE STREET GROUP, LLC | 26,515 | $86K |
| LuminArx Capital Management LP | 15,000 | $49K |
| NATIONAL BANK OF CANADA /FI/ | 1,803 | $6K |
| MORGAN STANLEY | 1,033 | $3K |
| Federation des caisses Desjardins du Quebec | 450 | $1K |
| ROYAL BANK OF CANADA | 289 | $1K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.